T-Wave Oversensing Discrimination for SVT Detection in ICDs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices (IMDs) face challenges in accurately detecting and discriminating between cardiac tachyarrhythmias, often leading to inappropriate cardioversion/defibrillation shocks due to false positive detections of ventricular tachycardia (VT) or ventricular fibrillation (VF) when supraventricular tachycardia (SVT) is present, especially when T-wave oversensing or atrial undersensing occurs.
Innovation Solution
A dual chamber ICD system with advanced sensing and discrimination techniques, including T-wave oversensing analysis and atrial undersensing detection, to differentiate between SVT and VT/VF, enabling accurate classification of cardiac rhythm episodes and reducing unnecessary shock therapy by accounting for oversensing and undersensing effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If T-wave oversensing analysis is performed to reduce false positive VT/VF detections, then reliability of rhythm classification is improved, but device complexity increases
Solution Approach 1:
The system performs preliminary detection of T-wave oversensing conditions before making final rhythm classification decisions. By identifying oversensing patterns in advance and adjusting detection criteria accordingly, the system prevents false positive VT/VF detections while maintaining reliable classification through a structured multi-step analysis process
Solution Approach 2:
The system introduces an intermediary analysis layer that evaluates multiple parameters (T-wave morphology, atrial rate, ventricular rate relationships) between the raw EGM signals and the final rhythm classification. This intermediary step resolves the contradiction by filtering out false detections through intermediate validation before committing to a therapy decision
2Measurement precision
If advanced sensing and discrimination techniques are implemented to differentiate SVT from VT/VF, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The detection algorithm is segmented into distinct analytical modules: T-wave oversensing detection, atrial rate analysis, ventricular rate analysis, and integrated rhythm classification. Each module focuses on specific discrimination criteria, improving measurement precision through specialized analysis while managing complexity through modular organization of detection functions
Solution Approach 2:
The system dynamically changes detection parameters based on identified conditions. When T-wave oversensing is detected, the system adjusts the ventricular rate zone thresholds and modifies discrimination criteria to account for the oversensing artifact, thereby maintaining high measurement precision across varying physiological and artifact conditions
3Reliability
If morphology discrimination is applied after T-wave oversensing determination, then reliability of SVT detection is improved, but loss of time in analysis increases
Solution Approach 1:
T-wave oversensing determination is performed as a preliminary step before morphology discrimination. By identifying oversensing conditions first, the system can selectively apply morphology analysis only when needed, improving SVT detection reliability while minimizing unnecessary analysis time in cases where oversensing patterns are already diagnostic
Solution Approach 2:
The system applies morphology discrimination selectively rather than continuously. When T-wave oversensing is detected, morphology analysis is applied to confirm SVT diagnosis. This partial application of the more time-consuming morphology discrimination only when initially indicated by T-wave analysis improves reliability while controlling overall analysis time
Data Source
AI summary
A medical device and method for detecting and classifying cardiac rhythm episodes that includes a sensing module to sense cardiac events; a therapy delivery module, and a detection module configured to determine intervals between the sensed cardiac events, determine a predetermined cardiac episode is occurring in response to the determined intervals, determine whether a ventricular rate is greater than an atrial rate in response to the determined intervals, determine whether oversensing is occurring in response to the ventricular rate being greater than the atrial rate, adjust the determined intervals in response to oversensing occurring to generate an adjusted ventricular rate, determine whether the cardiac episode is occurring in response to the adjusted ventricular rate, perform a supraventricular tachycardia (SVT) discrimination analysis in response to the cardiac episode occurring in response to the adjusted ventricular rate, and control the therapy delivery module to deliver therapy in response to the SVT discrimination analysis.